It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...
List today: Alnylam Pharmaceuticals, Inc. ALNY: This biopharmaceutical company has seen the Zacks Consensus Estimate for its ...
Rocket Lab stock shows 540% returns with risks like valuation and dilution with long-term potential similar to SpaceX's ...
Klein’s assertions are also finding traction in the market with the Defiance Quantum ETF (QTUM) surpassing the $1 billion in ...
JinkoSolar (JKS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates ...
Jefferies analyst Roger Song maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) yesterday and set a price target of ...
Altimmune (ALT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Trucchio from ...